Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smallpox Vaccine”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Not applicableStudy completedNCT00928577
What this trial is testing

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Who this might be right for
Smallpox
Emergent BioSolutions 14,108
Testing effectiveness (Phase 2)Study completedNCT00053495
What this trial is testing

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Who this might be right for
Smallpox
Emergent BioSolutions 353
Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing

Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351
Large-scale testing (Phase 3)Study completedNCT01056770
What this trial is testing

Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers

Who this might be right for
Smallpox
Seoul National University Hospital 88
Testing effectiveness (Phase 2)Study completedNCT01668537
What this trial is testing

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Who this might be right for
Smallpox
Bavarian Nordic 651
Large-scale testing (Phase 3)Active Not RecruitingNCT06844500
What this trial is testing

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Who this might be right for
NeonateMaternal TransmissionMpox+5 more
Jean-Pierre Van geertruyden 359
Early research (Phase 1)WithdrawnNCT00006630
What this trial is testing

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Who this might be right for
HealthyCommunicable Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00607243
What this trial is testing

Safety and Efficacy of CJ-50300 in Healthy Volunteers

Who this might be right for
Smallpox
Seoul National University Hospital 123
Testing effectiveness (Phase 2)Study completedNCT00026611
What this trial is testing

Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Testing effectiveness (Phase 2)Study completedNCT00316589
What this trial is testing

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 581
Testing effectiveness (Phase 2)Study completedNCT00038987
What this trial is testing

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 330
Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableNot Yet RecruitingNCT05513313
What this trial is testing

Assessment of Myocarditis After Replication-Deficient Smallpox Immunization

Who this might be right for
MyopericarditisSmall Pox
Womack Army Medical Center 2,350
Early research (Phase 1)Study completedNCT00189969
What this trial is testing

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Who this might be right for
Smallpox
Bavarian Nordic 50
Early research (Phase 1)WithdrawnNCT00389103
What this trial is testing

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Who this might be right for
SmallpoxAtopic Dermatitis
Sanofi Pasteur, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00857493
What this trial is testing

Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

Who this might be right for
Smallpox
Bavarian Nordic 120
Testing effectiveness (Phase 2)Study completedNCT00437021
What this trial is testing

MVA Post-Event: Administration Timing and Boost Study

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 226
Not applicableStudy completedNCT03745131
What this trial is testing

Cohort Study of Healthcare Workers Receiving Imvanex®

Who this might be right for
Monkeypox
Public Health England 120
Testing effectiveness (Phase 2)Study completedNCT00316602
What this trial is testing

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Bavarian Nordic 632
Load More Results